Jan-Inge Henter earned an MD from Uppsala University 1980 and completed a fellowship in Pediatrics in 1987. In 1990, he defended a PhD-thesis with focus on HLH. Since 2004, he is Professor of Pediatrics at the Karolinska Institute. He was Principal Investigator of the HLH-94 and HLH-2004 studies, and he has also studied the underlying biology in HLH. He is also interested in Langerhans cell histiocytosis and End-of-Life Care, and has more than 250 publications. He was President of the Histiocyte Society 2004-2007. During 2012–2017 he was Director of Research and Education of the Karolinska University Hospital. He describes himself as a curious and enthusiastic explorer of the World, and everything in it!

Dr. Muna Al Rasheed is a consultant and head of clinical haematology unit adan hospital MOH kuwait. She is also the Head of examinations committee for clinical hematology fellowship KIMS , she is a Graduate of faculty of medicine kuwait university , done her Internship in internal medicine university of Toronto and has a Fellowship in clinical hematology McMaster university as well as a Number of publications in itp / ttp/ pnh and other benign hematology

Dr. Hind Salama is a Consultant Adult Hematologist at King Abdulaziz Medical City, Riyadh, and Assistant Professor at King Saud bin Abdulaziz University for Health Sciences. She holds an MBBS from Gezira University and MRCP (UK), with fellowship training in hematology and bone marrow transplantation. She leads adult acute lymphoblastic leukemia and histiocytic clinics and established Saudi Arabia’s first adult histiocytic clinic. Dr. Salama has received multiple research awards, authored 46 publications, and is an ASH Choosing Wisely Champion.